National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 4156 [06-693]

Download as PDF 4156 Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITV—Schizophrenia and Aging. Date:≤ February 15, 2006. Time: 8:30 to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Tracy Waldeck, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6132, MSC 9608, Bethesda, MD 20852–9609. 301/435–0322. waldeckt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: January 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–690 Filed 1–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings wwhite on PROD1PC61 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commerical property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Integrated Preclinical/ Clinical AIDS Vaccine Development (IPCAVD). Date: February 15, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, 6700B Rockledge Drive, Room 3129, Bethesda, MD 20892, (Telephone Conference Call). VerDate Aug<31>2005 18:26 Jan 24, 2006 Jkt 208001 Contact Person: Eleazar Cohen, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3129, 6700 B Rockledge Drive, Bethesda, MD 20892, (301) 435–3564, ec17w@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials Network (2). Date: February 15, 2006. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 1202, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Kenneth E. Santora, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2550, ks216i@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials Network (8). Date: February 16, 2006. Time: 9 a.m. to 4 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 2217, 6700–B Rockledge Drive, MSC– 7616, Bethesda, MD 20892–7616, (301) 496– 2550, bgustafson@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Unit for HIV/AIDS Clinical Trials Network (14)–ZAL1–TP–A–M3. Date: February 17, 2006. Time: 10 a.m. to 4 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, 6700 B, Rockledge Drive, 3143, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Thames E. Pickett, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–496–2550, pickettte@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials Network (Sep 10). Date: February 21, 2006. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Darren D Sledjeski, PhD, Scientific Review Administrator, NIAID, PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 DEA, Scientific Review Program, Room 3253, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, 301–451–2638. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 18, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–693 Filed 1–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Units for HIV/AIDS Clinical Trials Network (3)—ZAI1–SR–A–M2. Date: February 13, 2006. Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call). Contact Person: Stefani T. Rudnick, Ph.D., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616. 301–496–2500. srudnick@niaid/nih/gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Partnerships to Develop Tools to Evaluate Women’s Health. Date: February 17, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814. E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 71, Number 16 (Wednesday, January 25, 2006)]
[Notices]
[Page 4156]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-693]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commerical property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Integrated Preclinical/Clinical 
AIDS Vaccine Development (IPCAVD).
    Date: February 15, 2006.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Room 3129, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Eleazar Cohen, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, Room 3129, 6700 B Rockledge Drive, 
Bethesda, MD 20892, (301) 435-3564, ec17w@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials 
Network (2).
    Date: February 15, 2006.
    Time: 12 p.m. to 6 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Room 1202, Bethesda, MD 20817, (Telephone 
Conference Call).
    Contact Person: Kenneth E. Santora, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892-7616, (301) 496-2550, ks216i@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials 
Network (8).
    Date: February 16, 2006.
    Time: 9 a.m. to 4 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review 
Administrator, NIAID, DEA, Scientific Review Program, Room 2217, 
6700-B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, (301) 
496-2550, bgustafson@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Unit for HIV/AIDS Clinical Trials 
Network (14)-ZAL1-TP-A-M3.
    Date: February 17, 2006.
    Time: 10 a.m. to 4 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, 6700 B, Rockledge Drive, 
3143, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Thames E. Pickett, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892-7616, 301-496-2550, pickettte@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials 
Network (Sep 10).
    Date: February 21, 2006.
    Time: 12 p.m. to 6 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Darren D Sledjeski, PhD, Scientific Review 
Administrator, NIAID, DEA, Scientific Review Program, Room 3253, 
6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-451-
2638.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 18, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-693 Filed 1-24-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.